COVID-19 in Children
Sign up for your free ClinicalKey trial today! Your first step in getting the right answers
when you need them.
Complications and Prognosis
Screening and Prevention
Admission decisions consider a combination of clinical presentation, supportive care requirement, underlying medical comorbidity, and caregiver's ability to provide home care
Admit all children with severe COVID-19 for expedient management, preferably at regional center with critical care and extracorporeal membrane oxygenation capability r5
Febrile neonates (younger than 28 days) require admission for further diagnosis, management, and monitoring r63
Most children with mild to moderate COVID-19 do not need admission, but decisions should be individualized
Standard treatment includes infection control and supportive care for all patients and medications for certain children
Infection controlmeasures include isolation, source control, and transmission precautions
Supportive care is the mainstay of management for overwhelming majority of pediatric patients; most children can be managed safely in the home environment r69
Medications to treat COVID-19 and coinfections and to prevent complications are indicated in certain children
Many therapies are under investigation for treatment of COVID-19 in pediatric population; consider use of the following only within a clinical trial: r1
Avoid potential harmful therapies not supported by evidence for treatment of acute COVID-19 in pediatric patients, such as the following: r1r5
Cookies are used by this site. To decline or learn more, visit our cookie notice.